Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Breaking the macrophage code in atherosclerosis.

Journal article

Monaco C. and Dib L., (2023), Cardiovasc Res, 119, 1622 - 1623

Modelling systemic risk factors in cardiovascular disease using single-cell biology

Journal article

Monaco C. and Dib L., (2023), NATURE CARDIOVASCULAR RESEARCH, 2, 496 - 497

Cell selectivity in succinate receptor SUCNR1/GPR91 signaling in skeletal muscle.

Journal article

Abdelmoez AM. et al, (2023), Am J Physiol Endocrinol Metab, 324, E289 - E298

CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis.

Journal article

Lutgens E. et al, (2023), Eur Heart J, 44, 1010 - 1012

Three-dimensional transesophageal echocardiographic evaluation of aortic plaque after cerebrovascular event.

Journal article

Rodrigues AC. et al, (2023), Rev Port Cardiol, 42, 149 - 155

A single-cell atlas of immune checkpoint molecules in atherosclerosis in ApoE-/- mice

Conference paper

Bazioti V. et al, (2023), EUROPEAN HEART JOURNAL, 44

Translational opportunities of single-cell biology in atherosclerosis.

Journal article

de Winther MPJ. et al, (2022), Eur Heart J

Load More